Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Marie Skłodowska-Curie Action · Running

ReTraCol Structural and molecular basis for transcription-replication collisions

Coordinator
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eV, Germany
Runs
1 May 2025 to 30 April 2027
Status
Running
EU funding
€202k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101210030

What the project is doing

In the project's own words, from its summary on CORDIS.

One of the sources of genome instability is the occurrence of transcription-replication collisions (TRCs). These collisions occur when the replication machinery collides with the transcription complex due to the presence of obstacles in the DNA template, such as DNA-bound proteins or structures known as R-loops, which are three-stranded nucleic acid structures that inhibit the normal progression of both systems. These R-loops are often formed during transcription, but their assembly is regulated by several cellular mechanisms that prevent the accumulation of TRCs.

TRCs can potentially cause deletions, chromosomal rearrangements, and loss of genetic information due to DNA double-strand breaks generated by the collision. High levels of TRCs have been found in several types of cancer, which is a growing global health concern. Although many studies have investigated the role of TRCs in normal and cancer cells, the detailed molecular mechanism behind TRCs remains to be elucidated. The ReTraCol project aims to bring together the fields of transcription and replication to gain a deeper molecular and structural understanding of R-loop-dependent TRCs using biochemical and cryo-EM techniques.

The expected results will reveal how the replication and transcription systems behave during a collision and describe the stepwise formation of TRCs. This project could lead to an understanding of the impact of TRCs in both normal and cancer cells, and potentially open new future investigations to use TRCs as a cancer target.

Topics

Who is involved

OrganisationCityCountryRole
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eVMunchenGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI